Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

NCT03695744 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Myeloma

Interventions

DRUG: Daratumumab
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Singapore General Hospital

Collaborators

[object Object]
[object Object]